MSCI ACWI IMI Virology Index

The MSCI ACWI IMI Virology Index is based on the MSCI ACWI IMI Index, its parent index, and includes large, mid and small-cap securities across Developed Markets (DM) and Emerging Markets (EM) countries. The index aims to represent the performance of a set of companies that are associated with research and development into, as well as the commercialization of anti-viral and vaccine products, which are used to treat a range of infectious diseases.
Get in touch
Document downloads
Index code
748382
Index type
Equity
Benchmark administrator
--
Div Yld (%)
2.36
P/E
30.52
P/E Fwd
26.48
P/BV
2.22
Number of constituents
38
Index Market Cap
$2.51 T
Largest constituent Market Cap
$166.86 B
Smallest constituent Market Cap
$5.20 B
Average constituent Market Cap
$66.26 B
Median constituent Market Cap
$54.25 B
Does this benchmark pursue ESG objectives?
No
Data as of July 31, 2025 

Want to learn more about MSCI indexes?
Get in touch.

Contact us